Depression is common, costly, debilitating, and associated with increased risk of suicide. It is
one of the leading global public health problems. Although existing available …

Mental disorders are rapidly increasing each year and have become a major challenge
affecting the social and financial well-being of individuals. There is a need for phenotypic …

Accumulating evidence suggests individuals with psychotic disorder show abnormalities in
metabolic and inflammatory processes. Recently, several studies have employed blood …

Stress-related disorders are among the biggest global health challenges. Despite significant
progress in understanding their neurocognitive basis, the promise of applying insights from …

Mindfulness-based interventions (MBIs) have a growing body of support in the literature and
are increasingly popular for treating a variety of mental health disorders. The two most …

Neuroinflammation is a critical component in neurodegenerative disorders. The
inflammasome, facilitates the cleavage of caspase-1, leading to the maturation and …

Currently, 280 million people worldwide experience depression, ranking it third in the global
burden of disease. The incidence of depression has risen due to the COVID-19 pandemic …

Abstract In Major Depressive Disorder, first evidence shows heightened mood-reactivity
toward daily events. Related longitudinal studies in remitted patients with recurrent major …

Whether remitted major depressive disorder (rMDD) and MDD present common or distinct
neuropathological mechanisms remains unclear. We performed a meta-analysis of task …

Major depressive disorder (MDD) patients demonstrate abnormal neural activation even
after complete remission. Many task-related functional magnetic resonance imaging (fMRI) …